I5Q-MC-CGAS - ClinicalTrials.gov - NCT03432286
I5Q-MC-CGAS - ClinicalTrials.gov - NCT03432286
Key Requirements
Key Requirements
Use the following checklist to help determine if this trial may be a good fit for you. Place a checkmark next to each criteria that you successfully meet.
Participants must
Participants must have been diagnosed with migraine with or without aura, with a history of migraine headaches for at least 6 months
Participants must NOT
Participants must not be allergic to multiple drugs or certain types of drugs sometimes used for headaches
Participants must not have a history of persistent headaches every day or cluster headaches
Participants must not have a history of head or neck injury that was associated with the start of migraine headaches or a change in the nature of their headaches
Participants must not have a history of brain tumors or birth defects of the brain
Trial Summary
Conditions the trial is for
Pediatric Migraine
What the trial is testing?
Galcanezumab, Placebo
Could I receive a Placebo?
yes
Enrollment Goal
325
Trial Dates
March 2018 - January 2024
Trial Phase
3
Key Requirements
Use the following checklist to help determine if this trial may be a good fit for you. Place a checkmark next to each criteria that you successfully meet.
Participants must
Participants must have been diagnosed with migraine with or without aura, with a history of migraine headaches for at least 6 months
Participants must NOT
Participants must not be allergic to multiple drugs or certain types of drugs sometimes used for headaches
Participants must not have a history of persistent headaches every day or cluster headaches
Participants must not have a history of head or neck injury that was associated with the start of migraine headaches or a change in the nature of their headaches
Participants must not have a history of brain tumors or birth defects of the brain
Trial Summary
Conditions the trial is for
Pediatric Migraine
What the trial is testing?
Galcanezumab, Placebo
Could I receive a Placebo?
yes
Enrollment Goal
325
Trial Dates
March 2018 - January 2024
Trial Phase
3
Trial Locations
Hide locations not currently recruiting